$INSM
INSMED Inc Stock $insm

$insm Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000110450622000014 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$53.11M	$56.12M	$40.21M
YoY Change	32.06%	35.5%	9.1%
Cost Of Revenue	$12.19M	$13.29M	$9.844M
YoY Change	23.84%	22.36%	16.66%
Gross Profit	$40.92M	$42.84M	$30.37M
YoY Change	34.73%	40.22%	6.85%
Gross Profit Margin	77.04%	76.32%	75.52%
Selling, General & Admin	$56.75M	$65.27M	$51.55M
YoY Change	10.08%	16.5%	0.39%
% of Gross Profit	138.69%	152.36%	169.74%
Research & Development	$84.36M	$76.35M	$61.39M
YoY Change	37.41%	12.6%	69.66%
% of Gross Profit	206.17%	178.24%	202.14%
Depreciation & Amortization	$1.286M	$3.650M	$2.388M
YoY Change	-46.15%	-4.95%	5.38%
% of Gross Profit	3.14%	8.52%	7.86%
Operating Expenses	$84.36M	$142.9M	$61.39M
YoY Change	37.41%	14.22%	69.66%
Operating Profit	-$89.83M	-$100.0M	-$83.83M
YoY Change	7.16%	5.82%	38.9%
Interest Expense	$3.291M	-$11.29M	$7.559M
YoY Change	-56.46%	51.12%	2.0%
% of Operating Profit
Other Income/Expense, Net	-$1.249M	-$2.652M	-$43.00K
YoY Change	2804.65%	-731.43%	-219.44%
Pretax Income	-$94.24M	-$113.0M	-$91.40M
YoY Change	3.1%	11.25%	37.8%
Income Tax	$400.0K	-$41.00K	$200.0K
% Of Pretax Income
Net Earnings	-$94.62M	-$113.0M	-$91.64M
YoY Change	3.25%	10.54%	38.09%
Net Earnings / Revenue	-178.17%	-201.3%	-227.88%
Basic Earnings Per Share	-$0.80		-$0.89
Diluted Earnings Per Share	-$0.80	-$952.8K	-$0.89
COMMON SHARES
Basic Shares Outstanding	118.9M shares	118.4M shares	103.0M shares
Diluted Shares Outstanding	118.9M shares		103.0M shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$635.1M	$766.8M	$409.8M
YoY Change	54.98%	43.92%	-4.45%
Cash & Equivalents	$515.7M	$716.8M	$409.8M
Short-Term Investments	$119.4M	$50.00M
Other Short-Term Assets	$31.15M	$28.90M	$21.60M
YoY Change	44.23%	20.41%	36.71%
Inventory	$64.15M	$67.01M	$52.06M
Prepaid Expenses
Receivables	$25.72M	$24.35M	$17.63M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$756.1M	$837.0M	$501.0M
YoY Change	50.92%	34.38%	1.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$52.68M	$52.96M	$52.68M
YoY Change	-0.02%	-1.85%	-10.15%
Goodwill	$136.1M	$136.1M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$29.55M	$50.04M
YoY Change
Other Assets	$57.20M	$50.99M	$46.40M
YoY Change	23.28%	90.26%	111.87%
Total Long-Term Assets	$397.2M	$406.5M	$191.4M
YoY Change	107.52%	134.6%	4.01%
TOTAL ASSETS
Total Short-Term Assets	$756.1M	$837.0M	$501.0M
Total Long-Term Assets	$397.2M	$406.5M	$191.4M
Total Assets	$1.153B	$1.244B	$692.4M
YoY Change	66.57%	56.19%	2.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.57M	$35.78M	$22.42M
YoY Change	116.62%	-16.5%	23.28%
Accrued Expenses	$53.29M	$60.67M	$41.29M
YoY Change	29.06%	60.46%	26.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$125.0K	$609.0K	$1.100M
YoY Change	-88.64%	-44.64%	-15.38%
Total Short-Term Liabilities	$125.2M	$135.2M	$81.40M
YoY Change	53.87%	13.77%	13.79%
LONG-TERM LIABILITIES
Long-Term Debt	$783.2M	$566.6M	$361.6M
YoY Change	116.6%	59.01%	6.05%
Other Long-Term Liabilities	$15.53M	$20.07M	$9.298M
YoY Change	66.98%	118.72%	-15.16%
Total Long-Term Liabilities	$798.7M	$586.7M	$370.9M
YoY Change	115.35%	60.51%	5.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$125.2M	$135.2M	$81.40M
Total Long-Term Liabilities	$798.7M	$586.7M	$370.9M
Total Liabilities	$1.033B	$833.0M	$490.8M
YoY Change	110.58%	60.12%	4.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.310B	-$2.265B	-$1.922B
YoY Change	20.16%	23.74%	19.92%
Common Stock	$1.193M	$1.187M	$1.033M
YoY Change	15.49%	15.47%	14.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$119.9M	$410.5M	$201.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.153B	$1.244B	$692.4M
YoY Change	66.57%	56.19%	2.35%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$94.62M	-$113.0M	-$91.64M
YoY Change	3.25%	10.54%	38.09%
Depreciation, Depletion And Amortization	$1.286M	$3.650M	$2.388M
YoY Change	-46.15%	-4.95%	5.38%
Cash From Operating Activities	-$105.2M	-$84.13M	-$128.3M
YoY Change	-18.02%	25.96%	121.42%
INVESTING ACTIVITIES
Capital Expenditures	$1.701M	-$1.142M	$1.181M
YoY Change	44.03%	-24.37%	-55.92%
Acquisitions
YoY Change
Other Investing Activities	-$99.71M	-$50.08M
YoY Change
Cash From Investing Activities	-$101.4M	-$51.22M	-$1.181M
YoY Change	8486.54%	3291.92%	-55.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.459M	5.710M	$6.703M
YoY Change	-3.64%	-52.46%	214.1%
NET CHANGE
Cash From Operating Activities	-$105.2M	-84.13M	-$128.3M
Cash From Investing Activities	-$101.4M	-51.22M	-$1.181M
Cash From Financing Activities	$6.459M	5.710M	$6.703M
Net Change In Cash	-$201.1M	-129.6M	-$123.0M
YoY Change	63.47%	130.31%	110.31%
FREE CASH FLOW
Cash From Operating Activities	-$105.2M	-$84.13M	-$128.3M
Capital Expenditures	$1.701M	-$1.142M	$1.181M
Free Cash Flow	-$106.9M	-$82.99M	-$129.5M
YoY Change	-17.46%	27.13%	113.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001104506
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q1	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2022Q1	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-30739
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	INSMED INC
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1972729
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	700 US Highway 202/206
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bridgewater
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08807
CY2022Q1	dei	City Area Code CityAreaCode	908
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	977-9900
CY2022Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	INSM
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	119517209	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	515704000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	716782000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	119415000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25722000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24351000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	64145000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	67009000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31154000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28898000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	756140000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	837040000	USD
CY2022Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	29551000	USD
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	50043000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52676000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52955000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17814000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9256000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31277000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33305000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72546000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73809000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	136110000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	136110000	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	57201000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	50990000	USD
CY2022Q1	us-gaap	Assets Assets	1153315000	USD
CY2021Q4	us-gaap	Assets Assets	1243508000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	48571000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	35784000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53289000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60665000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13639000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28581000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	125000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	609000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9625000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9527000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	125249000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	135166000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	783156000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	566588000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	66120000	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	75668000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23509000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	14103000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19875000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	21441000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15526000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20074000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	1033435000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	833040000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119345962	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119345962	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	118738266	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	118738266	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1193000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1187000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2428582000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2673556000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2309665000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2265243000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-230000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	968000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	119880000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	410468000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1153315000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1243508000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53107000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40214000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12191000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9844000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	84356000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61390000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56748000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51550000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-11618000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	142940000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	124047000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-89833000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-83833000	USD
CY2022Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	137000	USD
CY2021Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	33000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	3291000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	7559000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1249000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-43000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-94236000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-91402000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	385000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	239000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-94621000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-91641000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.89
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118929000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118929000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103040000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103040000	shares
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-94621000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91641000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-494000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-103000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-704000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95819000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91744000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	275884000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-91641000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-103000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6960000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10535000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	201636000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	410468000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-94621000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1198000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6816000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12823000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	119880000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-94621000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-91641000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	1286000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	2388000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	729000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12823000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10535000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	822000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5257000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	270000	USD
CY2022Q1	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	2369000	USD
CY2021Q1	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	5208000	USD
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-11618000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1798000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1066000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2240000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2754000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2752000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2056000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6289000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	19731000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13363000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-20273000	USD
CY2022Q1	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-22978000	USD
CY2021Q1	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-19793000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-105161000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-128281000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1701000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1181000	USD
CY2022Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	99706000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101407000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1181000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6818000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6961000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	359000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	258000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6459000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6703000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-969000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-246000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-201078000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-123005000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	716782000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	532756000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515704000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	409751000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2375000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	4271000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	635000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	672000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	515700000	USD
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	149000000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-94600000	USD
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	149000000.0	USD
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	50000000.0	USD
CY2022Q1	insm	Marketable Securities Additional MarketableSecuritiesAdditional	99700000	USD
CY2021Q1	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2022Q1	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	119400000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	29600000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	900000	USD
CY2022Q1	insm	Available For Sale Securities Gross Unrealized Gain Loss Number Of Securities AvailableForSaleSecuritiesGrossUnrealizedGainLossNumberOfSecurities	0	security
CY2021Q4	insm	Available For Sale Securities Gross Unrealized Gain Loss Number Of Securities AvailableForSaleSecuritiesGrossUnrealizedGainLossNumberOfSecurities	0	security
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-94621000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-91641000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118929000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	103040000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118929000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	103040000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.89
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to risks associated with extending credit to customers related to the sale of products. The Company does not require collateral to secure amounts due from its customers. The Company uses an expected loss methodology to calculate allowances for trade receivables. The Company's measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company does not currently have a material allowance for collectible trade receivables. The following table presents the percentage of gross product revenue represented by the Company's three largest customers as of the three months ended March 31, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.573%"><tr><td style="width:1.0%"/><td style="width:41.189%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.937%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.238%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third-party manufacturers and suppliers for manufacturing and supply of its products. The inability of the suppliers or manufacturers to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturers, or an adverse change in their business, could materially impact future operating results.</span></div>
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53107000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40214000	USD
CY2022Q1	insm	Revenue From Contract With Customer Excluding Assessed Tax Increase Decrease RevenueFromContractWithCustomerExcludingAssessedTaxIncreaseDecrease	12893000	USD
CY2022Q1	insm	Revenue From Contract With Customer Excluding Assessed Tax Increase Decrease Percent RevenueFromContractWithCustomerExcludingAssessedTaxIncreaseDecreasePercent	0.321
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30598000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	29541000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10607000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	18528000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22940000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	18940000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	64145000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	67009000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5100000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5100000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5100000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5100000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5100000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	73809000	USD
CY2022Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72546000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	49261000	USD
CY2021Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1263000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47998000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	136100000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	91023000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	90016000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	38347000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37061000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52676000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52955000	USD
CY2022Q1	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	14533000	USD
CY2021Q4	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	19410000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8746000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	10678000	USD
CY2022Q1	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	3817000	USD
CY2021Q4	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	6187000	USD
CY2022Q1	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	6559000	USD
CY2021Q4	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	6655000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2269000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2175000	USD
CY2022Q1	insm	Accrued Sales Allowances And Related Costs AccruedSalesAllowancesAndRelatedCosts	11516000	USD
CY2021Q4	insm	Accrued Sales Allowances And Related Costs AccruedSalesAllowancesAndRelatedCosts	8275000	USD
CY2022Q1	insm	Business Combination Deferred Payments Current BusinessCombinationDeferredPaymentsCurrent	4193000	USD
CY2021Q4	insm	Business Combination Deferred Payments Current BusinessCombinationDeferredPaymentsCurrent	4883000	USD
CY2022Q1	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	366000	USD
CY2021Q4	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	551000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1290000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1851000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	53289000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60665000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	100000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	200000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9287000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	341000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6541000	USD
CY2022Q1	insm	Lessee Operating Lease Lease Not Yet Commenced Amount LesseeOperatingLeaseLeaseNotYetCommencedAmount	34000000	USD
CY2022Q1	us-gaap	Secured Debt SecuredDebt	800000000	USD
CY2021Q4	us-gaap	Secured Debt SecuredDebt	800000000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16844000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11539000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	221873000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	783156000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	566588000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	225000000	USD
CY2022Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2022Q1	insm	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	575000000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	800000000	USD
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1969000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2063000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	822000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	350000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4907000	USD
CY2022Q1	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	2885000	USD
CY2021Q1	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	7226000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	406000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	333000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	3291000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	7559000	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	119345962	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	119345962	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	17500000	USD
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	23.25
CY2020Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13500000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	insm	Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross	135500	shares
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2000000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	USD
CY2021Q2	insm	Business Acquisition Consecutive Trading Day Period BusinessAcquisitionConsecutiveTradingDayPeriod	45	days

Files In Submission

Name	View Source	Status
0001104506-22-000014-index-headers.html	Edgar Link	pending
0001104506-22-000014-index.html	Edgar Link	pending
0001104506-22-000014.txt	Edgar Link	pending
0001104506-22-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insm-20220331.htm	Edgar Link	pending
insm-20220331.xsd	Edgar Link	pending
insm-20220331ex101.htm	Edgar Link	pending
insm-20220331ex102.htm	Edgar Link	pending
insm-20220331ex103.htm	Edgar Link	pending
insm-20220331ex104.htm	Edgar Link	pending
insm-20220331ex105.htm	Edgar Link	pending
insm-20220331ex311.htm	Edgar Link	pending
insm-20220331ex312.htm	Edgar Link	pending
insm-20220331ex321.htm	Edgar Link	pending
insm-20220331ex322.htm	Edgar Link	pending
insm-20220331_cal.xml	Edgar Link	unprocessable
insm-20220331_def.xml	Edgar Link	unprocessable
insm-20220331_htm.xml	Edgar Link	completed
insm-20220331_lab.xml	Edgar Link	unprocessable
insm-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INSM
INSMED Inc Stock $insm

2022 Q1 Form 10-Q Financial Statement

#000110450622000014 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM INSMED Inc Stock $insm

2022 Q1 Form 10-Q Financial Statement

#000110450622000014 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM
INSMED Inc Stock $insm